Randomized Comparison of Pazopanib and Doxorubicin as First-Line Treatment in Patients with Metastatic Soft Tissue Sarcoma Age 60 Years or Older: Results of a German Intergroup Study - Grünwald, V; Karch, A; Schuler, M (J Clin Oncol, 2020)
et al.